Tag: Biogen
FDA approves new breakthrough Alzheimer’s drug
The US Food and Drug Administration (FDA) on 6 January approved lecanemab, the second of a new category of medications approved for Alzheimer’s disease...
Alzheimer’s drug lecanemab slows cognitive decline in clinical trial
Eisai, a Japanese pharmaceutical company headquartered in Tokyo, and American multinational Biogen have released the results from their phase III clinical trial of lecanemab,...